Mucinous Breast Cancer Stage II Active Not Recruiting Phase 2 Trials for Denosumab (DB06643)

Also known as: Mucinous breast carcinoma / Mucinous carcinoma of breast

IndicationStatusPhase
DBCOND0053761 (Mucinous Breast Cancer Stage II)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02682693Denosumab as an add-on Neoadjuvant Treatment (GeparX)Treatment